New CLL Treatment Paradigm Nears In EU For AbbVie
EMA OKs New Indication For Venclyxto
The first chemotherapy-free, first-line treatment for chronic lymphocytic leukemia where dosing can be completed in one year has received the thumbs up by the European Medicines Agency.
